- Home
- BCRX vs JBLU Comparison
BCRX vs JBLU Comparison
Compare BCRX & JBLU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- JBLU
- Stock Information
- Founded
- BCRX 1986
- JBLU 1998
- Country
- BCRX United States
- JBLU United States
- Employees
- BCRX N/A
- JBLU N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- JBLU Air Freight/Delivery Services
- Sector
- BCRX Health Care
- JBLU Consumer Discretionary
- Exchange
- BCRX Nasdaq
- JBLU Nasdaq
- Market Cap
- BCRX 1.9B
- JBLU 1.6B
- IPO Year
- BCRX 1994
- JBLU N/A
- Fundamental
- Price
- BCRX $8.45
- JBLU $5.08
- Analyst Decision
- BCRX Strong Buy
- JBLU Sell
- Analyst Count
- BCRX 10
- JBLU 11
- Target Price
- BCRX $16.70
- JBLU $4.97
- AVG Volume (30 Days)
- BCRX 3.5M
- JBLU 18.8M
- Earning Date
- BCRX 08-04-2025
- JBLU 07-29-2025
- Dividend Yield
- BCRX N/A
- JBLU N/A
- EPS Growth
- BCRX N/A
- JBLU N/A
- EPS
- BCRX N/A
- JBLU N/A
- Revenue
- BCRX $557,506,000.00
- JBLU $9,138,000,000.00
- Revenue This Year
- BCRX $37.96
- JBLU N/A
- Revenue Next Year
- BCRX $8.82
- JBLU $7.77
- P/E Ratio
- BCRX N/A
- JBLU N/A
- Revenue Growth
- BCRX 45.85
- JBLU N/A
- 52 Week Low
- BCRX $6.02
- JBLU $3.34
- 52 Week High
- BCRX $11.31
- JBLU $8.31
- Technical
- Relative Strength Index (RSI)
- BCRX 46.82
- JBLU 66.49
- Support Level
- BCRX $8.08
- JBLU $4.22
- Resistance Level
- BCRX $8.64
- JBLU $5.20
- Average True Range (ATR)
- BCRX 0.33
- JBLU 0.23
- MACD
- BCRX 0.06
- JBLU 0.08
- Stochastic Oscillator
- BCRX 43.90
- JBLU 88.46
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About JBLU JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The company has one operating segment, Air Transportation Services, which provides services in the United States, the Caribbean, Latin America, Canada, and Europe. The majority of revenue is generated from the Domestic & Canada segment.